Perspective Therapeutics Inc (CATX)
2.645
-0.06
(-2.40%)
USD |
NYAM |
Oct 09, 16:00
2.645
0.00 (0.00%)
After-Hours: 17:17
Perspective Therapeutics Market Cap : 301.76M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 309.17M |
| October 07, 2026 | 280.65M |
| October 06, 2026 | 269.24M |
| October 05, 2026 | 293.20M |
| October 02, 2026 | 314.88M |
| October 01, 2026 | 310.31M |
| September 30, 2026 | 313.74M |
| September 29, 2026 | 298.91M |
| September 28, 2026 | 285.22M |
| September 25, 2026 | 287.50M |
| September 24, 2026 | 285.22M |
| September 23, 2026 | 298.91M |
| September 22, 2026 | 337.69M |
| September 21, 2026 | 338.84M |
| September 18, 2026 | 328.57M |
| September 17, 2026 | 328.57M |
| September 16, 2026 | 308.03M |
| September 15, 2026 | 311.46M |
| September 14, 2026 | 333.13M |
| September 11, 2026 | 320.58M |
| September 10, 2026 | 316.02M |
| September 09, 2026 | 341.12M |
| September 08, 2026 | 355.95M |
| September 04, 2026 | 357.09M |
| September 03, 2026 | 355.95M |
| Date | Value |
|---|---|
| September 02, 2026 | 353.67M |
| September 01, 2026 | 353.67M |
| August 31, 2026 | 360.51M |
| August 28, 2026 | 354.81M |
| August 27, 2026 | 362.79M |
| August 26, 2026 | 360.51M |
| August 25, 2026 | 375.34M |
| August 24, 2026 | 363.93M |
| August 21, 2026 | 376.48M |
| August 20, 2026 | 366.22M |
| August 19, 2026 | 397.02M |
| August 18, 2026 | 366.22M |
| August 17, 2026 | 367.36M |
| August 14, 2026 | 365.08M |
| August 13, 2026 | 353.67M |
| August 12, 2026 | 371.92M |
| August 11, 2026 | 362.79M |
| August 10, 2026 | 342.26M |
| August 07, 2026 | 342.26M |
| August 06, 2026 | 338.84M |
| August 05, 2026 | 335.21M |
| August 04, 2026 | 342.05M |
| August 03, 2026 | 343.19M |
| July 31, 2026 | 331.79M |
| July 30, 2026 | 340.91M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 33.35B |
| Rigel Pharmaceuticals, Inc. | 918.89M |
| Enanta Pharmaceuticals, Inc. | 363.56M |
| Insight Molecular Diagnostics, Inc. | 109.61M |
| BridgeBio Pharma, Inc. | 12.76B |
Market Cap Related Metrics
| PS Ratio | 602.87 |
| PEG Ratio | -4.789 |
| Price to Book Value | 0.9317 |
| Price | 2.645 |
| Earnings Yield | -50.23% |
| PEGY Ratio | -4.789 |